<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NVS
Novartis
$
()


  • Erasca announces two CTCSAs with Novartis for trametinib

    2/14/2024 - 08:05am
  • Biotech Alert: Searches spiking for these stocks today

    2/7/2024 - 11:01am
  • MorphoSys tells Bloomberg STAT story 'factually wrong'

    2/6/2024 - 13:48pm
  • Novartis will 'walk away from' deal to buy MorphoSys, STAT's Feuerstein says

    2/6/2024 - 11:52am
  • Novartis to acquire MorphoSys for EUR 68 per share, or aggregate of EUR 2.7B

    2/5/2024 - 16:59pm
  • What You Missed On Wall Street On Monday

    2/5/2024 - 16:26pm
  • Cytokinetics weakness a buying opportunity, says Truist

    2/5/2024 - 13:47pm
  • MorphoSys could fetch $3B-$4B in a takeout, says Wells Fargo

    2/5/2024 - 13:11pm
  • What You Missed On Wall Street This Morning

    2/5/2024 - 11:56am
  • Novartis in lead to acquire MorphoSys, Reuters says

    2/5/2024 - 10:20am
  • Novartis in advanced talks to buy MorphoSys, Reuters says

    2/5/2024 - 10:18am
  • U.S. sends offers for drugs selected for price negotiations, NY Times says

    2/1/2024 - 06:16am
  • Novartis sees 2024 core operating income to grow high single digit percentage

    1/31/2024 - 06:59am
  • Novartis reports Q4 core EPS $1.53 vs. $1.39 last year

    1/31/2024 - 06:57am
  • Novartis initiated with neutral view at Morgan Stanley, here's why

    1/23/2024 - 04:50am
dynamic_feed Breaking News